Development and Preclinical Evaluation of [(68)Ga]BMSH as a New Potent Positron Emission Tomography Tracer for Imaging Programmed Death-Ligand 1 Expression

Immunotherapy targeting the programmed death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) pathway has shown remarkable efficacy against various cancers, but the overall response rate (ORR) is still low. PD-L1 expression in tumors may predict treatment response to immunotherapy. Indeed, on...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yong, Li, Chengze, Li, Zhongjing, Wang, Qiong, Huang, Size, Liu, Qi, Liang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610256/
https://www.ncbi.nlm.nih.gov/pubmed/37895958
http://dx.doi.org/10.3390/ph16101487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610256/
https://www.ncbi.nlm.nih.gov/pubmed/37895958
http://dx.doi.org/10.3390/ph16101487

Ejemplares similares